Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Notice to Our Valued Users

Elsevier has made the difficult decision to close PracticeUpdate permanently. There will be no new content published, effective immediately. Although we are all disappointed by this news, we are incredibly grateful for your engagement and support over the years.

We thank the Editorial Boards, Advisory Boards, and Editorial Contributors for their many years of dedication to educating the healthcare community. Our appreciation extends to the many contributors who have shared their valuable time and expertise to help us parse the latest research over the years.

We encourage you to explore our other offerings such as ScienceDirect and ClinicalKey, which continue to provide valuable insights and information to help you excel in your practice.

If you have any questions or need assistance, please see the FAQs section or contact the support team. Thank you for being a part of the PracticeUpdate community!

featured

Published in Obesity, Metabolic Syndrome, and Prediabetes and

Journal Scan / Research · June 14, 2024

Association of SGLT2 Inhibitor Use With Risk of Osteoporotic Fracture in Older Women

Diabetes Research and Clinical Practice

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Sign in

Not a member?

Join for free

Additional Info

Article Citation

Diabetes Research and Clinical Practice

Association of sodium-glucose cotransporter 2 inhibitor use with risk of osteoporotic fracture among older women: A nationwide, population-based cohort study

Diabetes Res. Clin. Pract. 2024 May 18;[EPub Ahead of Print], S Lee, MH Yu, N Hong, KJ Kim, HK Kim, Y Rhee, M Lee, KM Kim

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Notice to Our Valued Users

Obesity, Metabolic Syndrome, and Prediabetes

Association of SGLT2 Inhibitor Use With Risk of Osteoporotic Fracture in Older Women

Additional Info

Association of sodium-glucose cotransporter 2 inhibitor use with risk of osteoporotic fracture among older women: A nationwide, population-based cohort study

Further Reading

Association Between Food Insecurity and Weight-Loss Efforts in Adults With Higher Weight

Early Combination Therapy With SGLT2 Inhibitors and GLP-1 Receptor Agonists or Dual GIP/GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes

Effects of GLP-1 Receptor Agonists on Kidney and Cardiovascular Disease Outcomes

Cumulative Impact of Type 2 Diabetes and Obstructive Sleep Apnoea on Cardiovascular, Liver, Diabetes-Related, and Cancer Outcomes

Stepwise Cardiovascular Risk Stratification in Patients With Diabetes Using Coronary CT Assessment

Overweight and Obesity Are Associated With the Risk of Serious Morbidity in Adolescents

Intensive BP Control in Patients With Type 2 Diabetes

Weight Maintenance Using Cost-Effective Antiobesity Medications After 1 Year of GLP-1 Receptor Agonist Therapy

Effect of Dapagliflozin on Renal Haemodynamics in Patients With Type 2 Diabetes and Glomerular Hyperfiltration

Trends in and Projections of Overweight and Obesity Prevalence Among Children, Adolescents, and Adults in the US (1990–2021 and Forecasts to 2050)

EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction–Associated Steatotic Liver Disease

Recently Updated